The Potioneer’s Gambit
Why the world’s most valuable elixir maker may be outmaneuvered by its free-brewing rival!
Looks can be deceiving: Why equities are more attractive than they appear
By adjusting for outlier companies and considering R&D spending’s impact on earnings, a clearer picture of equity value emerges, challenging the ‘expensive equities’ narrative.